Even a well-made product can be defective if it reaches users without adequate warning of its risks. Failure to warn is the third recognized category of product defect in Georgia, alongside manufacturing and design defects, and it works differently from the other two. The product may be built exactly as intended and designed reasonably, yet still expose people to foreseeable dangers that proper warnings would have prevented. This category also carries a feature that sets it apart from the rest of product liability law: the ordinary ten-year deadline does not apply to it. Understanding how failure-to-warn liability works, and where its limits lie, rounds out the picture of product defects.
Failure to Warn as a Defect
A failure-to-warn claim, sometimes called a marketing defect, arises when a product carries foreseeable risks that are not adequately disclosed to the people who use it. The theory recognizes that information is part of a product’s safety: a chemical without handling instructions, a tool without a hazard warning, or a medication without notice of a serious side effect can be dangerous precisely because users do not know what to guard against. Georgia courts have held that a manufacturer’s failure to warn of a product’s dangers may itself constitute a defect.
What Makes a Warning Adequate
The question in these cases is rarely whether a warning existed, but whether it was adequate. A warning that is buried, vague, or fails to convey the real danger may not satisfy the standard. Factors that bear on adequacy include:
- Whether the warning actually reached the people likely to use the product.
- Whether it clearly conveyed the nature and seriousness of the risk.
- Whether it explained how to avoid the danger.
- Whether its prominence matched the severity of the hazard.
A warning that fails on these points can leave a manufacturer exposed even where some warning was technically provided.
The Learned Intermediary Doctrine
For prescription drugs and medical devices, the warning often does not run to the patient at all. Under the learned intermediary doctrine, a manufacturer generally satisfies its duty by warning the prescribing physician rather than the patient directly, on the theory that the physician stands between the manufacturer and the patient and makes the treatment decision. The adequacy of the warning to the prescriber, not to the patient, becomes the central question. This doctrine is a defining feature of drug and device cases and shapes how failure-to-warn claims are litigated in that setting.
No Statute of Repose for Failure to Warn
The most distinctive feature of failure-to-warn liability in Georgia is timing. While most product claims face a ten-year statute of repose, Georgia courts have held that the repose does not apply to failure-to-warn claims. The statute itself, O.C.G.A. § 51-1-11(c), states that nothing relieves a manufacturer of the duty to warn of a danger once it becomes known. The practical effect is significant: a failure-to-warn claim can remain viable even when the ten-year window for other product theories has closed.
The Continuing Duty to Warn
Closely tied to the repose exception is the idea that the duty to warn does not end at the point of sale. When a manufacturer learns of a danger after a product is already in users’ hands, the duty to warn of nonobvious, foreseeable dangers continues and extends to users, consumers, and purchasers. A manufacturer that discovers a hazard years later cannot simply stay silent on the theory that the product is long sold.
The Obvious-Danger Limit
Failure-to-warn liability has boundaries. A manufacturer generally has no duty to warn of dangers that are obvious or generally known, and where a product is sold to a particular trade or profession, no duty to warn against risks already known to that group. Georgia courts have applied this limit, recognizing that warnings about the plainly obvious add nothing. The duty attaches to hidden or non-obvious dangers, not to risks any reasonable user would already understand.
Frequently Asked Questions
What is failure to warn?
It is a product defect that arises when foreseeable risks are not adequately disclosed to users. The product may be well made and reasonably designed but still dangerous because of inadequate warnings.
Does the ten-year repose apply to failure-to-warn claims?
Georgia courts have held that the statute of repose does not apply to failure-to-warn claims, because the duty to warn continues once a danger becomes known. This sets them apart from other product theories.
What is the learned intermediary doctrine?
For prescription drugs and devices, a manufacturer generally satisfies its duty by warning the prescribing physician rather than the patient. The adequacy of the warning to the prescriber is the central question.
Is there always a duty to warn?
No. There is generally no duty to warn of obvious or generally known dangers, or of risks already known to a profession the product is sold to. The duty applies to hidden, non-obvious hazards.
Failure-to-warn liability turns on the adequacy of warnings, the learned intermediary doctrine, and the repose exception. A Georgia personal injury attorney can frame whether a specific product’s warnings met the standard.